Dianthus Therapeutics DNTH
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$8.44M (12 inflow days, 8 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 45.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 15.05% to 16.59% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +974,346 | 2.7% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +451,597 | 1.3% |
| FMR | Mutual Fund | 2026/Q3 | +352,866 | 15.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +268,505 | 4.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +265,782 | 7.8% |
| Fisher Investments | Mutual Fund | 2026/Q3 | +249,510 | 0.5% |
| Pictet Asset Management Limited | Mutual Fund | 2026/Q3 | +214,995 | 0.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +177,018 | 4.5% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +165,318 | 2.5% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +138,405 | 2.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +228,901 | 11.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +958,527 | 4.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +948,119 | 7.4% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +634,099 | 5.7% |
| Jennison Associates LLC | Mutual Fund | 2026/Q3 | +536,627 | 1.8% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Nov 2026 | Ryan Savitz | Executive VP, CFO, Chief Business Officer & Treasurer | Derivative Exercise and Sale | -124,042 | $91.59 | – |
| 8 Nov 2026 | Ryan Savitz | Executive VP, CFO, Chief Business Officer & Treasurer | Intent to Sell (Form 144) | -124,042 | $86.03 | – |
| 16 Sep 2026 | Edward Carr | Chief Accounting Officer | Derivative Exercise and Sale | -20,000 | $104.39 | – |
| 31 Aug 2026 | Simrat Randhawa | Executive VP and Head of R&D | Derivative Exercise and Sale | -23,124 | $106.74 | 4,000 |
| 18 Aug 2026 | Simon Read | Independent Director | Derivative Exercise and Sale | -2,778 | $117.55 | – |
| 12 Aug 2026 | Adam Veness | Senior Vice President | Derivative Exercise and Retained | +15,000 | $18.17 | 15,000 |
| 9 Aug 2026 | Anne McGeorge | Independent Director | Derivative Exercise and Sale | -7,750 | $111.41 | – |
| 9 Aug 2026 | Simon Read | Independent Director | Derivative Exercise and Sale | -2,777 | $111.77 | – |
| 9 Aug 2026 | Adam Veness | Senior Vice President | Derivative Exercise and Sale | -20,000 | $111.18 | – |
| 6 Aug 2026 | Marino Garcia | Chief Executive Officer | Derivative Exercise and Sale | -166,000 | $110.76 | 65,292 |
| 8 Jul 2026 | Ryan Savitz | Executive VP, CFO, Chief Business Officer & Treasurer | Derivative Exercise and Sale | -31,249 | $101.97 | – |
| 16 Jun 2026 | Adam Veness | Senior Vice President | Derivative Exercise and Sale | -30,000 | $81.38 | – |
| 31 May 2026 | Simrat Randhawa | Executive VP and Head of R&D | Derivative Exercise and Sale | -26,530 | $91.37 | 4,000 |
| 20 May 2026 | Alison Lawton | Independent Chairperson | Other Derivative Acquisition | +6,090 | $89.63 | 6,090 |
| 20 May 2026 | Sujay Kango | Independent Director | Other Derivative Acquisition | +6,090 | $89.63 | 6,090 |
| 20 May 2026 | Anne McGeorge | Independent Director | Other Derivative Acquisition | +6,090 | $89.63 | 6,090 |
| 20 May 2026 | Jonathan Violin | Independent Director | Other Derivative Acquisition | +6,090 | $89.63 | 6,090 |
| 20 May 2026 | Steven Romano | Independent Director | Other Derivative Acquisition | +6,090 | $89.63 | 6,090 |
| 20 May 2026 | Paula Soteropoulos | Independent Director | Other Derivative Acquisition | +6,090 | $89.63 | 6,090 |
| 20 May 2026 | Simon Read | Independent Director | Other Derivative Acquisition | +6,090 | $89.63 | 6,090 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,276,833 | 16.6% | 10.1 |
| 15 Oct 2026 | 8,986,958 | 16.1% | 10.2 |
| 30 Sep 2026 | 9,140,581 | 16.3% | 8.3 |
| 15 Sep 2026 | 8,829,663 | 15.8% | 14.4 |
| 31 Aug 2026 | 8,429,902 | 15.1% | 15.3 |
| 14 Aug 2026 | 8,418,356 | 15.1% | 11.5 |
No comments yet — be the first to weigh in on DNTH.
Sign in to join the discussion.